DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Kaufman B, Mackey JR, Clemens MR. et al.
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive
metastatic breast cancer: results from the randomized phase III TAnDEM study.
J Clin Oncol 2009;
27: 5529-5537
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.